CLYM
Price
$2.13
Change
+$0.03 (+1.43%)
Updated
Sep 26 closing price
Capitalization
144.34M
52 days until earnings call
PDSB
Price
$1.02
Change
-$0.01 (-0.97%)
Updated
Sep 26 closing price
Capitalization
47.97M
46 days until earnings call
Interact to see
Advertisement

CLYM vs PDSB

Header iconCLYM vs PDSB Comparison
Open Charts CLYM vs PDSBBanner chart's image
Climb Bio
Price$2.13
Change+$0.03 (+1.43%)
Volume$351.26K
Capitalization144.34M
PDS Biotechnology
Price$1.02
Change-$0.01 (-0.97%)
Volume$445.6K
Capitalization47.97M
CLYM vs PDSB Comparison Chart in %
Loading...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLYM vs. PDSB commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLYM is a Hold and PDSB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (CLYM: $2.13 vs. PDSB: $1.02)
Brand notoriety: CLYM and PDSB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLYM: 59% vs. PDSB: 91%
Market capitalization -- CLYM: $144.34M vs. PDSB: $47.97M
CLYM [@Biotechnology] is valued at $144.34M. PDSB’s [@Biotechnology] market capitalization is $47.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLYM’s FA Score shows that 1 FA rating(s) are green whilePDSB’s FA Score has 1 green FA rating(s).

  • CLYM’s FA Score: 1 green, 4 red.
  • PDSB’s FA Score: 1 green, 4 red.
According to our system of comparison, CLYM is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLYM’s TA Score shows that 5 TA indicator(s) are bullish while PDSB’s TA Score has 3 bullish TA indicator(s).

  • CLYM’s TA Score: 5 bullish, 4 bearish.
  • PDSB’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CLYM is a better buy in the short-term than PDSB.

Price Growth

CLYM (@Biotechnology) experienced а -7.79% price change this week, while PDSB (@Biotechnology) price change was -2.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

CLYM is expected to report earnings on Nov 18, 2025.

PDSB is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLYM($144M) has a higher market cap than PDSB($48M). CLYM YTD gains are higher at: 18.333 vs. PDSB (-37.423). CLYM has higher annual earnings (EBITDA): -4.68M vs. PDSB (-32.36M). CLYM has more cash in the bank: 84.7M vs. PDSB (31.9M). CLYM has less debt than PDSB: CLYM (639K) vs PDSB (18.5M). CLYM (0) and PDSB (0) have equivalent revenues.
CLYMPDSBCLYM / PDSB
Capitalization144M48M300%
EBITDA-4.68M-32.36M14%
Gain YTD18.333-37.423-49%
P/E RatioN/AN/A-
Revenue00-
Total Cash84.7M31.9M266%
Total Debt639K18.5M3%
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLYMPDSB
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 25 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VHIBF8.080.09
+1.13%
VITALHUB CORP
ASBFF26.66N/A
N/A
Associated British Foods plc
SSSAF38.00N/A
N/A
SHURGARD SELF STORAGE LTD.
CLSPF4.48N/A
N/A
CANADIAN LIFE COS SPLIT CORP.
DGTEF0.04-0.01
-17.89%
DIGITAL ASSET TECHNOLOGIES INC.

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with IPSC. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
+1.43%
IPSC - CLYM
43%
Loosely correlated
+4.39%
KYTX - CLYM
37%
Loosely correlated
-3.94%
ABOS - CLYM
37%
Loosely correlated
-4.05%
PDSB - CLYM
37%
Loosely correlated
-0.97%
CABA - CLYM
36%
Loosely correlated
+2.16%
More

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with DYN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
-0.97%
DYN - PDSB
45%
Loosely correlated
+4.53%
IDYA - PDSB
42%
Loosely correlated
+4.44%
RGNX - PDSB
42%
Loosely correlated
+3.10%
VRDN - PDSB
42%
Loosely correlated
+5.82%
NUVL - PDSB
42%
Loosely correlated
+4.99%
More